Oncology Institute insider buys 12,000 TOI shares
Chernett Jorey, a ten percent owner of Oncology Institute, Inc., reported an open-market purchase of 12,000 shares of Common Stock on June 4, 2026 at $4.75 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chernett Jorey, a ten percent owner of Oncology Institute, Inc., reported an open-market purchase of 12,000 shares of Common Stock on June 4, 2026 at $4.75 per share. Following this transaction, Jorey directly holds 10,579,858 shares of Oncology Institute common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,000 | $4.75 | $57K |
Key Figures
Key Terms
Common Stock financial
open-market purchase financial
Form 4 regulatory
ten percent owner regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TOI report on this Form 4?
What are Chernett Jorey’s TOI holdings after this transaction?
Was the TOI insider transaction a buy or sell?
Is the TOI Form 4 transaction a derivative or common stock trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.